ArticleJNCI cancer spectrum2019
Consequences of Performing Parallel Dose Finding Trials in Heterogeneous Groups of Patients.
Bethany Jablonski Horton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it